AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines
November 09, 2023 at 05:05 AM EST
AstraZeneca shares jumped 3% after the Anglo-Swedish drugmaker said it expects its full-year revenues will increase at a higher rate than previously forecast
